17-45962044-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001377265.1(MAPT):​c.-17-277A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 152,102 control chromosomes in the GnomAD database, including 2,132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.14 ( 2132 hom., cov: 32)

Consequence

MAPT
NM_001377265.1 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.372

Publications

15 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 17-45962044-A-G is Benign according to our data. Variant chr17-45962044-A-G is described in ClinVar as [Benign]. Clinvar id is 1296619.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPTNM_001377265.1 linkc.-17-277A>G intron_variant Intron 1 of 12 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkc.-17-277A>G intron_variant Intron 1 of 12 1 NM_001377265.1 ENSP00000262410.6 A0A7I2PJZ2

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21817
AN:
151984
Hom.:
2134
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0431
Gnomad AMI
AF:
0.276
Gnomad AMR
AF:
0.176
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.0740
Gnomad FIN
AF:
0.0651
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.185
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.143
AC:
21806
AN:
152102
Hom.:
2132
Cov.:
32
AF XY:
0.134
AC XY:
9978
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0430
AC:
1784
AN:
41508
American (AMR)
AF:
0.176
AC:
2684
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
834
AN:
3472
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5170
South Asian (SAS)
AF:
0.0740
AC:
357
AN:
4822
European-Finnish (FIN)
AF:
0.0651
AC:
689
AN:
10586
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.217
AC:
14752
AN:
67960
Other (OTH)
AF:
0.182
AC:
384
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
918
1836
2753
3671
4589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
302
Bravo
AF:
0.148
Asia WGS
AF:
0.0310
AC:
109
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Aug 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
2.5
DANN
Benign
0.77
PhyloP100
-0.37
PromoterAI
-0.049
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111520035; hg19: chr17-44039410; API